The cell surface activating receptor NKp30 was up-regulated in Vδ1 T cells and Vδ2 T cells of patients with advanced HCC, and TIM3 was up-regulated in circulating γδ T cells of patients with advanced HCC. This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.